Project Details
Description
A Phase III, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subjects with Painful Diabetic Peripheral Neuropathy
| Status | Finished |
|---|---|
| Effective start/end date | 3/1/16 → 12/31/19 |
Funding
- ViroMed Co., Ltd.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.